ASH · NYSE · Chemicals - Specialty

Ashland (ASH)

Supplies specialty ingredients and additives through its business segments.

$70.18
After hours+0.51 (+0.73%)
At close$69.67(+0.88%)
Loading prices…

Ashland Inc.ASH
Materials

Organizes additives and specialty ingredients across Life Sciences, Personal Care, Specialty Additives, and Intermediates. The portfolio serves consumer and industrial markets after a long transition away from refining.

Supplies additives and specialty ingredients to consumer and industrial markets. Life Sciences, Personal Care, Specialty Additives, and Intermediates are the reported segments, serving architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals. The current portfolio reflects a long exit from refining, marketing, distribution, water technologies, and Valvoline.

Customers are spread across more than 100 countries, making international markets integral to the operating model. The company has legacy environmental assessment and remediation obligations at former and current operating facilities and service-station properties. Work at identified Superfund or analogous state-law sites remains subject to EPA or state-agency oversight and to cost estimates.

Company facts

CEOGuillermo Novo
ListedMay 8, 1950
ExchangeNYSE
HeadquartersWilmington, DE
CountryUnited States
Employees2,900
CIK0001674862
ISINUS0441861046

Market cap$3.16B
EPS (ttm)$1.13
P/E (ttm)61.12
ROE2.8%
P/B1.69
P/S1.72
Dividend yieldDiv yield2.42%
Beta0.89vs XLB 0.79

Price target$78.00+12.5%Average of 25 analysts
ConsensusBuy16 of 25 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 6, 2026Morgan StanleyReiterate
Rating: Target: $58
Rating: Equal WeightTarget: $78
Jul 31, 2026Deutsche BankReiterate
Rating: Target: $60
Rating: BuyTarget: $85
Jul 30, 2026UBSReiterate
Rating: Target: $72
Rating: BuyTarget: $83
Jul 29, 2026BMO CapitalReiterate
Rating: Target: $71
Rating: OutperformTarget: $75
Jul 29, 2026Mizuho SecuritiesTarget
Target: $70
Target: $77

Next report
Nov 3, 26
in 42 days
EPS estimate
$1.32
Revenue estimate
$502.4M
Fiscal quarter
Q4 FY26

EPSReportedEstimate

Jan '25Apr '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$0.28$0.99$1.04$1.08$0.26$0.91$1.02Pending
Estimate$0.20$1.10$1.15$1.17$0.23$0.97$0.99$1.32
Surprise+40.0%−10.0%−9.6%−7.7%+13.0%−6.2%+3.6%

RevenueReportedEstimate

Jan '25Apr '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$405.0M$479.0M$463.0M$478.0M$386.0M$482.0M$497.0MPending
Estimate$429.1M$502.6M$476.6M$482.3M$400.9M$485.6M$486.0M$502.4M
Surprise−5.6%−4.7%−2.8%−0.9%−3.7%−0.7%+2.3%
Estimate$1.32
ReportedDue Nov 3, 2026
Estimate$502.4M
ReportedDue Nov 3, 2026
View details

Debt to equity78.90%
Current ratio304.70%

ProfitabilityRevenueNet incomeNet margin

Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$522.0M$405.0M$479.0M$463.0M$478.0M$386.0M$482.0M$497.0M
Net income$16.0M−$165.0M$31.0M−$742.0M$32.0M−$12.0M$16.0M$16.0M
Net margin3.1%0.0%6.5%0.0%6.7%0.0%3.3%3.2%

GrowthOperating income

Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Operating income$31.0M$23.0M$51.0M−$16.0M$61.0M−$6.0M$39.0M$41.0M
YoY growthTurned profitTurned profit+142.9%Loss narrowed+96.8%Turned loss−23.5%Turned profit

Balance sheet, Jun 30, 2026Cash & short-term investments $440.0M · Total debt $1.48B · Total assets $4.58B · Shareholders' equity $1.87B

Revenue
$497.0M
Operating income
$41.0M
Net income
$16.0M
View details

Dividend yield
2.42%
Next ex-date
Dec 1, 26
estimated · in 70 days
Annual dividend
$1.67
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Feb '25May '25Aug '25Dec '25Feb '26Jun '26Sep '26
Dividend$0.405$0.405$0.415$0.415$0.415$0.415$0.42$0.42
Annual yield2.05%2.66%3.29%2.92%2.84%2.66%2.87%2.21%
Ex-dateNov 29Feb 28May 30Aug 29Dec 1Feb 27Jun 1Sep 1
Payment dateDec 15Mar 15Jun 15Sep 15Dec 15Mar 15Jun 15Sep 15
View details

Institutions115.43%52.86M shares
370 holders · as of Jun 30, 2026
Insiders1.09%498.4K shares
15 holders · as of Aug 12, 2026
Adds to116.52%

45.79M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 116.52%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
12.47%5.71Mas of Jun 30, 2026
Standard Investments LLCInstitution
9.88%4.53Mas of Jun 30, 2026
Franklin Resources IncInstitution
7.90%3.62Mas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
5.43%2.49Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
5.38%2.46Mas of Jun 30, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • Dow

    Cellulose ethers for construction and coatings formulations

  • Innospec

    Personal-care and construction formulation additives

  • Stepan

    Surfactants, emollients, and emulsifiers for personal care

CompareAfter hours

CompanyPriceChange
Ashland$70.18+0.73%$3.16B61.116.61.7+7.3%
Dow$28.20+0.04%$20.42B14.80.5+19.7%
Innospec$96.08−0.08%$2.28B18.916.81.2+11.8%
Stepan$64.38−0.02%$1.40B19.70.6+15.0%
Median18.916.80.6+15.0%